Friday, September 01, 2017
Tuesday, August 15, 2017
The role had been mapped out and loaded on our website ready to advertise as soon as we received confirmation of our next project. I knew our next project would tip us into securing an extra person to join our team. That project turned out to be the TTM2 and TAME Trials combined (more about that later).
Bryn adapted quickly to our way of working, our customer focus and the matrix of software we use. He has a neuroscience degree; the TTM2 & TAME Trials are looking at neurological outcomes after people have experienced a cardiac arrest and Bryn has been enjoying reading the protocols for both these trials while he gets up to speed on the project.
Read more about Bryn »
Posted by Audrey at Tuesday, August 15, 2017
Tuesday, August 08, 2017
Spiral is going to the ANZICS-CTG Winter Research Forum in Queenstown. The forum provides an informal opportunity for investigators to gain early advice and feedback on research proposals, to explore issues relevant to study design and conduct in ANZ ICUs and to foster a collaborative approach to study development within the CTG.
We are very pleased and excited to support the ANZICS-CTG community and to attend the forum where we expect to learn more about the trials undertaken by the CTG.
Five of the trials listed on the program are, or will be, using our software; these are TTM2, TAME, TARGET, PLUS and REMAP-CAP. This presents a great opportunity for us to learn more about these and other projects, to gain further insights into the world of ICU research and catch up with everyone that we work with.
Look out for the competition - we will be giving away an iPad for the most relevant photo on Twitter. Details to follow later.
Forum website »
Posted by Audrey at Tuesday, August 08, 2017
Friday, July 14, 2017
This week we launched another study – the TASI Study.
This is a small, low budget pilot trial that will test the potential overall benefit of the TightRope versus syndesmotic screw fixation for ankle injuries. You can read more about it on the Spinnaker website »
The trial has been running for over 12 months using the classic envelope system for randomisation. Patients were previously randomised into this multi-centre trial by telephoning a central coordinator. This placed a significant burden on the coordinator to always be available by mobile phone. In one easily implemented package our randomisation module has removed all that difficulty and put randomising patients in the hands of the local registrars.
With only 160 patients in the pilot there was not the budget for our full Spinnaker package. Our stand alone Randomisation Module is useful and surprisingly affordable package for pilot studies like the TASI Trial.
Posted by Audrey at Friday, July 14, 2017